Oxbryta Alternatives Compared
| Oxbryta | Casgevy | Voxelotor |
|
|---|
| Oxbryta (voxelotor) | Casgevy (exagamglogene autotemcel) | Voxelotor |
|
|---|---|---|---|
|
Prescription only
Prescribed for Sickle Cell Disease. Oxbryta may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Beta Thalassemia, Sickle Cell Disease. Casgevy may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Sickle Cell Disease. Voxelotor may also be used for purposes not listed in this medication guide. |
Related suggestions Sickle Cell Disease
|
| More about Oxbryta (voxelotor) | More about Casgevy (exagamglogene autotemcel) | More about Voxelotor | |
| Ratings & Reviews | |||
|
Oxbryta has an average rating of 6.5 out of 10 from a total of 7 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 33% reported a negative effect. |
Be the first to share your experience with this drug. |
Voxelotor has an average rating of 6.7 out of 10 from a total of 8 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 29% reported a negative effect. |
|
| Drug Class | |||
| Side Effects | |||
| Generic Availability | |||
|
N/A |
N/A |
N/A |
|
| Pricing and Coupons * Prices are without insurance | |||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms Available | |||
|
N/A |
N/A |
|
| Brand Names | |||
|
N/A |
N/A |
N/A |
|
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||
|
35.5 hours |
N/A |
35.5 hours |
|
| CSA Schedule ** View glossary of terms | |||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | |||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
|
| Drug Interactions | |||
|
A total of 357 drugs are known to interact with Oxbryta:
|
A total of 93 drugs are known to interact with Casgevy:
|
A total of 357 drugs are known to interact with Voxelotor:
|
|
| Alcohol/Food/Lifestyle Interactions | |||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
| Disease Interactions | |||
| First Approval Date | |||
|
November 25, 2019 |
N/A |
November 25, 2019 |
|
| WADA Class View World Anti-Doping Agency classifications. | |||
|
N/A |
N/A |
N/A |
|
| More Information | |||
| Patient resources | |||
| Professional Resources | |||
| Related Treatment Guide | |||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.